A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics

A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics

Rapid innovation in (epi)genetics and biomarker sciences is driving a new drug development and product development pathway, with the personalized medicine era dominated by biologic therapeutics and companion diagnostics. Companion diagnostics (CDx) are tests and assays that detect biomarkers and spe...

Full description

Bibliographic Details
Main Authors: Dee eLuo, James A Smith, Nick A Meadows, Katie eManescu, Kim eBure, Benjamin eDavies, Rob eHorne, David L DiGiusto, David A Brindley
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-01-01
Series:Frontiers in Genetics
Subjects:
personalized medicine
Stratified Medicine
Commercialization
companion diagnostic
Combinational therapy
Healthcare translation
Online Access:http://journal.frontiersin.org/Journal/10.3389/fgene.2015.00357/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fgene.2015.00357/full

Similar Items